Cargando…
MicroRNA-29 Fine-tunes the Expression of Key FOXA2-Activated Lipid Metabolism Genes and Is Dysregulated in Animal Models of Insulin Resistance and Diabetes
MicroRNAs (miRNAs) have emerged as biomarkers of metabolic status, etiological factors in complex disease, and promising drug targets. Recent reports suggest that miRNAs are critical regulators of pathways underlying the pathophysiology of type 2 diabetes. In this study, we demonstrate by deep seque...
Autores principales: | Kurtz, C. Lisa, Peck, Bailey C.E., Fannin, Emily E., Beysen, Carine, Miao, Ji, Landstreet, Stuart R., Ding, Shengli, Turaga, Vandana, Lund, P. Kay, Turner, Scott, Biddinger, Sudha B., Vickers, Kasey C., Sethupathy, Praveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141370/ https://www.ncbi.nlm.nih.gov/pubmed/24722248 http://dx.doi.org/10.2337/db13-1015 |
Ejemplares similares
-
Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver
por: Kurtz, C. Lisa, et al.
Publicado: (2015) -
MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients
por: Greco, Simona, et al.
Publicado: (2012) -
Plasma MicroRNA Signature of Alcohol Consumption: The Rotterdam Study
por: Karabegović, Irma, et al.
Publicado: (2022) -
Treatment with Nitrate, but Not Nitrite, Lowers the Oxygen Cost of Exercise and Decreases Glycolytic Intermediates While Increasing Fatty Acid Metabolites in Exercised Zebrafish
por: Axton, Elizabeth R, et al.
Publicado: (2019) -
First trimester plasma microRNAs levels predict Matsuda Index-estimated insulin sensitivity between 24th and 29th week of pregnancy
por: Légaré, Cécilia, et al.
Publicado: (2022)